Pozavarovalnica Sava, d.d. (LJSE:POSR)

Slovenia flag Slovenia · Delayed Price · Currency is EUR
60.50
-1.00 (-1.63%)
At close: Aug 1, 2025

Intra-Cellular Therapies Revenue

Pozavarovalnica Sava, d.d. had revenue of 220.45M EUR in the quarter ending March 31, 2025, with 11.17% growth. This brings the company's revenue in the last twelve months to 869.25M, up 13.04% year-over-year. In the year 2024, Pozavarovalnica Sava, d.d. had annual revenue of 847.72M with 15.64% growth.

Revenue (ttm)
869.25M
Revenue Growth
+13.04%
P/S Ratio
1.08
Revenue / Employee
306.18K
Employees
3,044
Market Cap
937.61M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024847.72M114.64M15.64%
Dec 31, 2023733.08M105.88M16.88%
Dec 31, 2022627.20M-203.47M-24.49%
Dec 31, 2021830.66M146.50M21.41%
Dec 31, 2020684.16M74.08M12.14%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition